Achieve Life Sciences (ACHV) Profit After Tax (2010 - 2026)

Achieve Life Sciences (ACHV) has 17 years of Profit After Tax data on file, last reported at -$10.2 million in Q1 2026.

• Quarterly Profit After Tax rose 20.88% year-over-year to -$10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$51.9 million (down 12.5% YoY) and the FY2025 annual result came in at -$54.6 million, down 37.09% from the prior year.
• Profit After Tax improved to -$10.2 million in Q1 2026, from -$14.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$5.5 million in Q4 2023 to a low of -$14.6 million in Q4 2025.
• A 5-year average of -$10.4 million and a median of -$10.5 million in 2022 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax soared 51.25% — and 2024, when it tumbled 125.11%.
• Tracing ACHV's Profit After Tax over 5 years: stood at -$11.2 million in 2022, then soared by 51.25% to -$5.5 million in 2023, then tumbled by 125.11% to -$12.3 million in 2024, then declined by 18.44% to -$14.6 million in 2025, then soared by 30.36% to -$10.2 million in 2026.
• The last three Profit After Tax figures came in at -$10.2 million (Q1 2026), -$14.6 million (Q4 2025), and -$14.4 million (Q3 2025), per Business Quant data.